These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2877109

  • 21. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A, Nakahara H, Hara Y.
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [Abstract] [Full Text] [Related]

  • 22. Effects of amosulalol, a combined alpha 1- and beta-adrenoceptor-blocking agent, on ischemic myocardial energy metabolism in dogs.
    Hayase N, Chiba K, Ichihara K.
    J Pharm Sci; 1993 Mar; 82(3):291-5. PubMed ID: 8095542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
    Kennedy I, Levy GP.
    Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive and adrenoceptor blocking properties of new sulfonamide-substituted phenylethylamines.
    Takenaka T, Shiono K, Honda K, Asano M, Miyazaki I, Maeno H.
    Clin Exp Hypertens A; 1982 Aug; 4(1-2):125-37. PubMed ID: 7074981
    [Abstract] [Full Text] [Related]

  • 29. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ, Sulpizio AC, Ashton DJ, Hieble JP, Ruffolo RR.
    Chirality; 1989 Aug; 1(4):265-70. PubMed ID: 2577144
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of airway obstruction induced by propranolol and YM-09538 (a combined alpha- and beta-adrenoceptor blocking drug).
    Tomioka K, Yamada T, Takenaka T.
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):97-107. PubMed ID: 6124220
    [Abstract] [Full Text] [Related]

  • 35. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity.
    Shibasaki K, Uchida W, Shirai Y, Inagaki O, Asano M, Takenaka T.
    Arch Int Pharmacodyn Ther; 1994 Sep; 328(2):213-24. PubMed ID: 7710306
    [Abstract] [Full Text] [Related]

  • 37. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL, Liou SF, Liang JC, Huang YC, Chiang LC, Wu JR, Lin YT, Chen IJ.
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [Abstract] [Full Text] [Related]

  • 38. Beneficial effect of amosulalol and phentolamine on post-hypoxic recovery of contractile force and energy metabolism in rabbit hearts.
    Tanonaka K, Matsumoto M, Minematsu R, Miyake K, Murai R, Takeo S.
    Br J Pharmacol; 1989 Jun; 97(2):513-23. PubMed ID: 2569344
    [Abstract] [Full Text] [Related]

  • 39. Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
    Nichols AJ, Hamada A, Adejare A, Miller DD, Patil PN, Ruffolo RR.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):671-6. PubMed ID: 2537407
    [Abstract] [Full Text] [Related]

  • 40. Central sympathoinhibitory action of a new type of alpha-1 adrenoceptor antagonist, YM-617, in rats.
    Yoshioka M, Togashi H, Abe M, Ikeda T, Matsumoto M, Saito H.
    J Pharmacol Exp Ther; 1990 May; 253(2):427-31. PubMed ID: 1692588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.